Relapsed and/or Refractory Cutaneous T-cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed and/or Refractory Cutaneous T-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Bortezomib/Dexamethasone Therapy in Patients With Relapsed and/or Refractory Cutaneous T-cell Lymphoma (NCT03487133) | Samsung Medical Center | 2017-09-19 |
Track Relapsed and/or Refractory Cutaneous T-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.